HealthDay News — For patients with heart failure with preserved ejection fraction, tirzepatide yields a reduced risk for a composite of death from cardiovascular causes or worsening heart failure, ...

Epicardial adipose tissue (EAT) accumulation is thought to play a role in the pathophysiology of heart failure (HF) with mid‐range ejection fraction and HF with preserved ejection fraction, but its ...

Heart failure is broken down into big two categories based on the ejection fraction (EF) of the heart, which is the percentage of blood that the left ventricle squeezes out during each beat.

[21] This was a smaller study that enrolled 74 patients 65 years and older with NYHA class II or III heart failure (defined by the Framingham criteria) and an ejection fraction ≥40%. Background ...

A gene therapy for heart failure ... in NYHA classification, left ventricular ejection fraction (LVEF), peak oxygen (VO2), and six-minute walk test scores, with heart-failure-related ...

In patients with HF with reduced ejection fraction, HTN is treated ... College of Cardiology/American Heart Association classification of heart failure. ACE-I = Angiotensin converting enzyme ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

This classification has not been widely adopted in practice ... or as part of the pathophysiological process in acute left ventricular failure. However, in some cases the presenting illness may be ...

"Heart failure is a complex condition that affects many, and this treatment provides the option for our patients to be treated right here at home.” ...